Skip to main content
Clinical Trials/JPRN-jRCT1050210166
JPRN-jRCT1050210166
Active, not recruiting
未知

Study on the relationship between cognitive function and expression of metabolism-related genes in peripheral blood mononuclear cells

Taguchi Akihiko0 sites20 target enrollmentFebruary 2, 2022
ConditionsdementiaD000544

Overview

Phase
未知
Intervention
Not specified
Conditions
dementia
Sponsor
Taguchi Akihiko
Enrollment
20
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
Taguchi Akihiko

Eligibility Criteria

Inclusion Criteria

  • 1\)disease: Elderly healthy people and dementia patients
  • Dementia patients must be diagnosed with probable Alzheimer's disease according to the NIA\-AA Alzheimer's disease diagnostic criteria.
  • In the MMSE test, dementia patients should have a score of 23 or less, and the healthy group should have a score of 28 or more.
  • 2\)others: For patients with dementia, written consent must be obtained from a substitute other than the person himself (Do not exclude the acquisition of consent from the dementia patient).

Exclusion Criteria

  • 1\)Diabetes
  • 2\)During cancer disease treatment, less than 5 years after the end of cancer treatment
  • 3\)Thyroid disease
  • 4\)Infectious diseases (AIDS, hepatitis B, hepatitis C)
  • 5\)Fever at the time of blood collection
  • 6\)Chronic subdural hematoma
  • 7\)Normal pressure hydrocephalus
  • 8\)During hemodialysis (or doctors say the need for hemodialysis soon future)
  • 10\)During home oxygen therapy
  • 11\)Smoking within the last 12 months

Outcomes

Primary Outcomes

Not specified

Similar Trials